Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Multicenter, Double-Blind, Placebo-Controlled, Trial of VLTS-589 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease

NCT00068133 is registered in ClinicalTrials.gov with Valentis as lead sponsor.

NCT NCT00068133
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00068133 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Multicenter, Double-Blind, Placebo-Controlled, Trial of VLTS-589 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease
Lead sponsor
Valentis
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2003
Completion date
June 30, 2005
Enrollment
100
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

intermittent claudication, peripheral vascular disease